MPN Recruiting Phase 3 Trials for Hydroxyurea (DB01005)

IndicationStatusPhase
DBCOND0076875 (MPN)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02611973Hydroxyurea Versus Aspirin and Hydroxyurea in Essential ThrombocythemiaTreatment